@misc{indiciae6875c8db850b,
  title = {Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against Omicron subvariants including EG.5},
  author = {Kaku, Y. and Kosugi, Y. and Uriu, K. and Ito, J. and Kuramochi, J. and Sadamasu, K. and Yoshimura, K. and Asakura, H. and Nagashima, M. and The Genotype to Phenotype Japan (G2P-Japan) Consortium, and Sato, K.},
  year = {2023},
  doi = {10.1101/2023.08.08.552415},
  url = {https://www.biorxiv.org/content/10.1101/2023.08.08.552415v1},
  note = {Source identifier: 10.1101/2023.08.08.552415}
}